Chemical Structure (Colchicine 01)
Colchicine Tablet, Film Coated
Product Images NDC 63629-2167
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 63629-2167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Colchicine 02)
The image is a graph titled "Pain Relief on Low and High Doses of Colchicine Tablets, USP and Placebo". The graph shows the percentage of patients who experienced pain relief after taking different doses of colchicine or placebo, with the x-axis representing the time elapsed in minutes and the y-axis representing the percentage of patients who experienced relief. The graph depicts three lines: one for the low dose of colchicine (1.8 mg), one for the high dose of colchicine (4.8 mg), and one for placebo. At the beginning of the test, all three lines start at 0% improvement. As time passes, the percentage of patients who experience pain relief increases across all three lines, with the two colchicine lines showing higher rates of improvement than the placebo line. At the end of the test period (100 minutes), the low-dose colchicine line is at about 65% improvement, the high-dose colchicine line is at about 75% improvement, and the placebo line is at about 45% improvement.*
Label (Lbl636292167)
Colchicine Tablets, USP is a prescription medication that contains 0.6mg of Colchicine, USP that is utilized to treat gout and familial Mediterranean fever. The medication ought to be kept out of reach of children and stored in a tight, light-resistant container at around 20°C to 25°C (68°F to 77°F). It is advised to dispense the drug with a child-resistant closure. *
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
